• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸葡萄糖胺的抗反应特性。

Antireactive properties of glucosamine sulfate.

作者信息

Setnikar I, Cereda R, Pacini M A, Revel L

机构信息

Rotta Research Laboratorium S.p.A., Monza, Italy.

出版信息

Arzneimittelforschung. 1991 Feb;41(2):157-61.

PMID:1645969
Abstract

Glucosamine (CAS 3416-24-8) is an aminomonosaccharide naturally occurring in the human body. It was tested for antiinflammatory activities and it showed to protect against the edema provoked in the rat paw by carrageenin, dextran, formalin, but not against the edema provoked by specific inflammation mediators, such as bradykinin, serotonin, histamine. Glucosamine protected against pleurities provoked in the rat by carrageenin, but not against that provoked by bradykinin. Furthermore glucosamine protected against peritonitis provoked in the rat by formalin and in the mouse by acetic acid. Glucosamine did not show antinoceptive properties against writings provoked by i.p. phenylquinone in the mouse. Glucosamine did not show inhibiting activities on cyclooxygenase or on the proteolytic enzymes in the inflamed paw of the rat, but it was able to inhibit in vitro superoxide generation and lysosomial enzymes of the liver. The potency of glucosamine on the antiinflammatory tests was lower than that of acetylsalicylic acid and much lower than that of indomethacin. Its acute toxicity, however, and notably the toxicity on the gastrointestinal tract is very low, practically absent. The pharmacological therapeutic index of glucosamine with regard to the antiinflammatory activities seems therefore comparable or superior to that of the known non-steroidal anti-inflammatories.

摘要

氨基葡萄糖(CAS 3416-24-8)是一种天然存在于人体中的氨基单糖。对其抗炎活性进行了测试,结果表明它能预防角叉菜胶、右旋糖酐、福尔马林诱发的大鼠足爪水肿,但对缓激肽、5-羟色胺、组胺等特定炎症介质诱发的水肿无效。氨基葡萄糖能预防角叉菜胶诱发的大鼠胸膜炎,但对缓激肽诱发的胸膜炎无效。此外,氨基葡萄糖能预防福尔马林诱发的大鼠腹膜炎以及乙酸诱发的小鼠腹膜炎。氨基葡萄糖对小鼠腹腔注射苯醌诱发的扭体反应没有镇痛作用。氨基葡萄糖对大鼠炎症足爪中的环氧化酶或蛋白水解酶没有抑制活性,但它能够在体外抑制肝脏中超氧化物的产生和溶酶体酶的活性。氨基葡萄糖在抗炎试验中的效力低于乙酰水杨酸,远低于吲哚美辛。然而,其急性毒性,尤其是对胃肠道的毒性非常低,几乎不存在。因此,就抗炎活性而言,氨基葡萄糖的药理学治疗指数似乎与已知的非甾体抗炎药相当或更高。

相似文献

1
Antireactive properties of glucosamine sulfate.硫酸葡萄糖胺的抗反应特性。
Arzneimittelforschung. 1991 Feb;41(2):157-61.
2
The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.2-(8-甲基-10,11-二氢-11-氧代二苯并[b,f]氧杂卓-2-基)丙酸(AD-1590)的药理学特征,一种具有强效解热活性的新型非甾体抗炎药。
Arzneimittelforschung. 1983;33(11):1555-69.
3
Nerve growth factor inhibits some acute experimental inflammations.神经生长因子可抑制某些急性实验性炎症。
Arch Int Pharmacodyn Ther. 1989 May-Jun;299:269-85.
4
Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.新型非甾体抗炎药屈昔康的药理特性
Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22.
5
Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties--outline of toxicological and pharmacokinetic data.酮洛芬(19.583法定参考标准品)(2-(3-苯甲酰基苯基)丙酸)。主要药理特性——毒理学和药代动力学数据概述。
Scand J Rheumatol Suppl. 1976;1976(0):33-44.
6
Mechanism of anti-inflammatory action of etodolac.依托度酸的抗炎作用机制。
Arzneimittelforschung. 1991 Mar;41(3):235-9.
7
Antireactive properties of "chondroprotective" drugs.“软骨保护”药物的抗反应特性。
Int J Tissue React. 1992;14(5):253-61.
8
Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.脂氧素A4抑制小鼠急性水肿:对阿司匹林诱导的抗水肿机制的启示。
Prostaglandins Other Lipid Mediat. 2006 Sep;80(3-4):123-35. doi: 10.1016/j.prostaglandins.2006.05.016. Epub 2006 Jul 7.
9
Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.新型非甾体抗炎药依托度酸的药理特性
Arzneimittelforschung. 1991 Mar;41(3):228-35.
10
Antiinflammatory properties of the new antirheumatic agent 4-acetylaminophenylacetic acid.新型抗风湿药物4-乙酰氨基苯乙酸的抗炎特性
Arzneimittelforschung. 1990 Jun;40(6):693-7.

引用本文的文献

1
GLUCOSAMINE SULFATE EFFICACY IN TREATING KNEE OSTEOARTHRITIS: A FOLLOW-UP STUDY.硫酸氨基葡萄糖治疗膝骨关节炎的疗效:一项随访研究。
Acta Clin Croat. 2022 Nov;61(3):436-448. doi: 10.20471/acc.2022.61.03.09.
2
Postulated Adjuvant Therapeutic Strategies for COVID-19.新冠肺炎的假定辅助治疗策略
J Pers Med. 2020 Aug 5;10(3):80. doi: 10.3390/jpm10030080.
3
Precolumn derivatization LC-MS/MS method for the determination and pharmacokinetic study of glucosamine in human plasma and urine.柱前衍生化液相色谱-串联质谱法测定人血浆和尿液中氨基葡萄糖并进行药代动力学研究
J Pharm Anal. 2012 Feb;2(1):19-28. doi: 10.1016/j.jpha.2011.08.003. Epub 2011 Oct 24.
4
Efficacy of treatment with glucosamine sulfate in patients with knee effusion due to osteoarthritis.硫酸氨基葡萄糖治疗骨关节炎膝关节积液的疗效。
Pak J Med Sci. 2013 May;29(3):847-50.
5
Specialty supplement use and biologic measures of oxidative stress and DNA damage.专业补充剂的使用与氧化应激和 DNA 损伤的生物标志物。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2312-22. doi: 10.1158/1055-9965.EPI-13-0470. Epub 2013 Aug 5.
6
Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.一项关于氨基葡萄糖联合硫酸软骨素治疗乳腺癌女性芳香化酶抑制剂相关性关节症状的 II 期研究。
Support Care Cancer. 2013 Apr;21(4):1077-87. doi: 10.1007/s00520-012-1628-z. Epub 2012 Nov 1.
7
A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis.硫酸氨基葡萄糖与硫酸氨基葡萄糖联合非甾体抗炎药治疗轻至中度膝关节骨关节炎的临床研究
ScientificWorldJournal. 2012;2012:902676. doi: 10.1100/2012/902676. Epub 2012 Apr 1.
8
Role of glucosamine in the treatment for osteoarthritis.氨基葡萄糖在骨关节炎治疗中的作用。
Rheumatol Int. 2012 Oct;32(10):2959-67. doi: 10.1007/s00296-012-2416-2. Epub 2012 Mar 30.
9
Comparison of glucose derivatives effects on cartilage degradation.葡萄糖衍生物对软骨降解影响的比较。
BMC Musculoskelet Disord. 2010 Jul 15;11:162. doi: 10.1186/1471-2474-11-162.
10
Glucosamine therapy for treating osteoarthritis.用于治疗骨关节炎的葡萄糖胺疗法。
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD002946. doi: 10.1002/14651858.CD002946.pub2.